Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs placebo/open control
Death or dependence (mRS 4 to 6) at day 90 · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Antifibrinolytic drug(s) showed no clear difference in death or dependence (mRS 4–6) compared with placebo/open control (high certainty).
1 finding from 1 review
- Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage 2023 · Cochrane Headline outcomes onlyRR 1 [0.93, 1.07]5 studies · 2683 participantsHigh